Amin et al identified features of a chromophobe renal cell carcinoma associated with a more aggressive clinical course. A patient with one or more of these risk factors may benefit from more aggressive management. The authors are from Cedars-Sinai Medical Center in Los Angeles, Emory University, Henry Ford Hospital, the National Medical Center in Mexico City, and University Hospital Zurich.